In order to study 5-nitro-2-furaldehyde derivatives having more effective antibacterial activity, four new N©ù-(5-nitro-2-furfurylidene)-N©ö-substituted sulfanilamides-N©ö-3,4-dimethyl-5-isoxazoyl-N©ù-5-nitro-2-furfurylidene sulfanilamide, N©ö-4,6-dimethyl-2-pyrimidyl-N©ù-5- nitro-2-furfurylidene sulfanilamide, N©ö-6-methoxy-3-pyridazinyl-N©ù-5-nitro-2-furaldehyde sulfanilamide, and N©ö-2,6-dimethoxy-4-pyrimidyl-N©ù-5-nitro-2-furfurylidene sulfanilamide - were synthesized which were obtained by the condensation of 5-nitro-2-furaldehyde with sulfa drugs such as sulfisoxazole, sulfamethazine, sulfamethoxypyridazine, and sulfadimethoxine. All compounds were tested for antibacterial activity in vitro on the following micro-organisms : Staphylococcus aureus, Bacillus subtilis, Escherichia coli, and Proteus vulgaris. Each compound exhibited a fair bacteriostatic activity against each microorganism. Above all, sulfisoxazole derivatives showed higher activity than the others. Each compound was most active against Staphylococcus aureus, whereas least active against Proteus vulgaris.
|